Clearbridge Health Limited (SGX:1H3)
Singapore · Delayed Price · Currency is SGD 0.0010
-0.0010 (-50.00%)
At close: Mar 20, 2026
Clearbridge Health Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9.93 | 9.9 | 10.41 | 16.41 | 11.44 | |
Revenue Growth (YoY) | 0.26% | -4.84% | -36.59% | 43.44% | -68.44% |
Cost of Revenue | 4.95 | 5.12 | 5.28 | 6.84 | 5.08 |
Gross Profit | 4.98 | 4.78 | 5.13 | 9.58 | 6.36 |
Selling, General & Admin | 4.58 | 5.11 | 5.58 | 6.21 | 6.77 |
Amortization of Goodwill & Intangibles | 0.01 | 0.01 | 0.01 | 0.06 | 0.11 |
Other Operating Expenses | 2.43 | 2.37 | 3.05 | 3.81 | 3.23 |
Operating Expenses | 8.07 | 8.64 | 9.82 | 11.58 | 11.74 |
Operating Income | -3.1 | -3.86 | -4.69 | -2.01 | -5.38 |
Interest Expense | -0.33 | -0.68 | -0.73 | -0.87 | -1.72 |
Interest & Investment Income | 0.01 | 0.02 | 0.17 | 0.08 | 0.05 |
Currency Exchange Gain (Loss) | -0.42 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.56 | 0.26 | -18.77 | 0.28 | -2.88 |
EBT Excluding Unusual Items | -4.4 | -4.26 | -24.02 | -2.52 | -9.93 |
Impairment of Goodwill | -8.59 | - | -10.37 | - | - |
Gain (Loss) on Sale of Investments | - | - | -0.15 | -8.77 | -6.62 |
Gain (Loss) on Sale of Assets | - | - | 0.01 | 0.17 | 2.01 |
Asset Writedown | - | - | - | -0.12 | - |
Other Unusual Items | - | 0.11 | 0.27 | - | 0.97 |
Pretax Income | -12.99 | -4.14 | -34.27 | -11.24 | -13.57 |
Income Tax Expense | 0.08 | 0.07 | -1.9 | 0.19 | 0.32 |
Earnings From Continuing Operations | -13.07 | -4.21 | -32.37 | -11.43 | -13.89 |
Earnings From Discontinued Operations | - | 0.05 | -0.09 | 1.33 | -3.59 |
Net Income to Company | -13.07 | -4.17 | -32.47 | -10.09 | -17.48 |
Minority Interest in Earnings | 0.16 | 0.56 | 0.27 | -1.05 | -2.49 |
Net Income | -12.91 | -3.61 | -32.2 | -11.14 | -19.97 |
Net Income to Common | -12.91 | -3.61 | -32.2 | -11.14 | -19.97 |
Shares Outstanding (Basic) | 3,290 | 687 | 619 | 618 | 617 |
Shares Outstanding (Diluted) | 3,290 | 687 | 619 | 618 | 617 |
Shares Change (YoY) | 378.73% | 11.07% | 0.14% | 0.12% | 2.75% |
EPS (Basic) | -0.00 | -0.01 | -0.05 | -0.02 | -0.03 |
EPS (Diluted) | -0.00 | -0.01 | -0.05 | -0.02 | -0.03 |
Free Cash Flow | -2.71 | -2.08 | -3.99 | -2.66 | -3.74 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 |
Gross Margin | 50.11% | 48.26% | 49.27% | 58.35% | 55.61% |
Operating Margin | -31.21% | -38.95% | -45.05% | -12.22% | -47.02% |
Profit Margin | -130.00% | -36.43% | -309.40% | -67.90% | -174.53% |
Free Cash Flow Margin | -27.32% | -21.04% | -38.34% | -16.18% | -32.68% |
EBITDA | -2.93 | -3.56 | -4.36 | -0.34 | -2.37 |
EBITDA Margin | -29.54% | -35.93% | -41.90% | -2.10% | -20.67% |
D&A For EBITDA | 0.17 | 0.3 | 0.33 | 1.66 | 3.02 |
EBIT | -3.1 | -3.86 | -4.69 | -2.01 | -5.38 |
EBIT Margin | -31.21% | -38.95% | -45.05% | -12.22% | -47.02% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.